Clinical Trials · NCT02104037

Liraglutide in Spinal Fluid

CompletedN/ALiraglutide (Approved)
Phase
N/A
Recruitment status
Completed
Sponsor
Mikkel Christensen
Enrollment
8
Start date
Jan 2012
Locations
1 site, Denmark
Primary endpoint
cerebrospinal fluid concentration of liraglutide
View Liraglutide compound reference